Aristeia Capital »

Zenas Biopharma shares owned by Aristeia Capital

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $518k 500k 1.04

More positions owned by Aristeia Capital

Wix.com SHS (WIX)
SM Energy (SM)
Strategy Note 12/0 (Principal)
Iac Com New (IAC)
SPDR S&P 500 ETF Trust Tr Unit Put Option (SPY)
Invesco QQQ Trust Series 1 Unit Ser 1 Put Option (QQQ)
Evergy Note 4.500%12/1 (Principal)
Guardant Health Note 11/1 (Principal)
HEICO Corporation Cl A (HEI.A)
Super Micro Computer Note 3.500% 3/0 (Principal)
Alibaba Group Holding Note 0.500% 6/0 (Principal)
Strategy Note 3/0 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)
Liberty Broadband Corporation Com Ser C (LBRDK)
Atlanta Braves Holdings Com Ser C (BATRK)

View all positions for Aristeia Capital

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Calamos Advisors
Graham Capital Management
Woodline Partners
Millennium Management
Aristeia Capital

View all funds holding Zenas Biopharma